Laura Brege

Laura A. Brege currently works at Pacira Biosciences, Inc., as Chairman from 2025, Council on International Educational Exchange, Inc., as Chairman, ACADIA Pharmaceuticals, Inc., as Independent Director from 2008, Pacira Pharmaceuticals, Inc. (California), as Director from 2011, Ohio University Foundation, as Director, Edgewise Therapeutics, Inc., as Independent Non-Executive Director from 2020, Mirum Pharmaceuticals, Inc., as Independent Director from 2019, and T-Knife Therapeutics, Inc., as Director from 2021.
Ms. Brege also formerly worked at Nodality, Inc., as President, Chief Executive Officer & Director from 2012 to 2015, Delcath Systems, Inc., as Independent Director from 2013 to 2014, Dynavax Technologies Corp., as Independent Director from 2015 to 2020, Angiotech Pharmaceuticals, Inc., as Director from 2007 to 2011, StubHub Events, Inc., as Director, Aratana Therapeutics, Inc., as Independent Director from 2014 to 2019, Avexus, Inc., as Director, The Bay Area Bioscience Association, as Independent Director, Portola Pharmaceuticals LLC, as Independent Director from 2015 to 2021, Cervantes Life Science Partners LLC, as Managing Director from 2015 to 2018, California Life Sciences Association, as Director, HLS Therapeutics, Inc., as Independent Director from 2019 to 2024, The Cooper Cos., Inc., as Treasurer & Vice President from 1982 to 1988, COR Therapeutics, Inc., as Chief Financial Officer & Senior Vice President from 1991 to 1999, Onyx Pharmaceuticals, Inc., as Chief Operating & Business Officer, Executive VP from 2006 to 2011, Flextronics Corp., as Chief Financial Officer & Vice President from 1988 to 1991, and Red Rock Capital Management, Inc., as General Partner from 1999 to 2008.
Ms. Brege received her undergraduate degree from Honors Tutorial College and Masters Business Admin degree from The University of Chicago Booth School of Business.